Clinical Trial Update: Effect of Liraglutide on Microbiome in Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of liraglutide on the microbiome in individuals with obesity and weight loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Federico II University | Conditions: Obesity, Weight Loss | Phase 4 | Status: UNKNOWN